StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-12 | $0.09 | $0.08 | -2.35% | 0.4M |
| 05-13 | $0.08 | $0.08 | +3.58% | 0.8M |
| 05-14 | $0.08 | $0.08 | +1.88% | 0.4M |
| 05-15 | $0.08 | $0.07 | -18.33% | 1.6M |
| 05-18 | $0.07 | $0.07 | +2.14% | 0.4M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $39.48M | $159.83M | $118.18M | $77.57M |
Operating Income | $125.00K | $-2.82M | $1.71M | $290.00K |
Net Income | $-3.79M | $-14.48M | $-9.85M | $-6.72M |
EPS (Diluted) | $-0.01 | $-0.04 | $-0.03 | $-0.02 |
Total Assets | $201.19M | $202.56M | $205.60M | $204.37M |
Total Liabilities | $147.74M | $137.83M | $136.55M | $131.20M |
Cash & Equivalents | $7.94M | $8.88M | $6.60M | $6.14M |
Free Cash Flow OCF − CapEx | $576.00K | $6.53M | $3.13M | $1.01M |
Shares Outstanding | 398.91M | 396.91M | 394.45M | 392.01M |
MARIMED INC
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.